Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College London, 2020 | 5093 | 2020 |
Estimates of the severity of coronavirus disease 2019: a model-based analysis R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... The Lancet infectious diseases 20 (6), 669-677, 2020 | 4487 | 2020 |
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 4200* | 2020 |
Strategies for containing an emerging influenza pandemic in Southeast Asia NM Ferguson, DAT Cummings, S Cauchemez, C Fraser, S Riley, ... Nature 437 (7056), 209-214, 2005 | 2369 | 2005 |
Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections WHO Ebola Response Team New England Journal of Medicine 371 (16), 1481-1495, 2014 | 2045 | 2014 |
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions S Riley, C Fraser, CA Donnelly, AC Ghani, LJ Abu-Raddad, AJ Hedley, ... Science 300 (5627), 1961-1966, 2003 | 1508 | 2003 |
Factors that make an infectious disease outbreak controllable C Fraser, S Riley, RM Anderson, NM Ferguson Proceedings of the National Academy of Sciences 101 (16), 6146-6151, 2004 | 1372 | 2004 |
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong CA Donnelly, AC Ghani, GM Leung, AJ Hedley, C Fraser, S Riley, ... The lancet 361 (9371), 1761-1766, 2003 | 1339 | 2003 |
Modeling infectious disease dynamics in the complex landscape of global health H Heesterbeek, RM Anderson, V Andreasen, S Bansal, D De Angelis, ... Science 347 (6227), aaa4339, 2015 | 770 | 2015 |
Large-scale spatial-transmission models of infectious disease S Riley Science 316 (5829), 1298-1301, 2007 | 716 | 2007 |
The global impact of COVID-19 and strategies for mitigation and suppression PGT Walker, C Whittaker, O Watson, M Baguelin, KEC Ainslie, S Bhatia, ... Imperial College London 26, 1-19, 2020 | 705 | 2020 |
Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic RM Anderson, C Fraser, AC Ghani, CA Donnelly, S Riley, NM Ferguson, ... Philosophical Transactions of the Royal Society of London. Series B …, 2004 | 648 | 2004 |
Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 610 | 2021 |
Global circulation patterns of seasonal influenza viruses vary with antigenic drift T Bedford, S Riley, IG Barr, S Broor, M Chadha, NJ Cox, RS Daniels, ... Nature 523 (7559), 217-220, 2015 | 575 | 2015 |
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility S Cauchemez, C Fraser, MD Van Kerkhove, CA Donnelly, S Riley, ... The Lancet infectious diseases 14 (1), 50-56, 2014 | 456 | 2014 |
The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients GM Leung, AJ Hedley, LM Ho, P Chau, IOL Wong, TQ Thach, AC Ghani, ... Annals of internal medicine 141 (9), 662-673, 2004 | 447 | 2004 |
Estimates of the severity of COVID-19 disease R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... MedRxiv, 2020.03. 09.20033357, 2020 | 429 | 2020 |
Community transmission of monkeypox in the United Kingdom, April to May 2022 R Vivancos, C Anderson, P Blomquist, S Balasegaram, A Bell, L Bishop, ... Eurosurveillance 27 (22), 2200422, 2022 | 381 | 2022 |
Report 3: transmissibility of 2019-nCoV N Imai, A Cori, I Dorigatti, M Baguelin, CA Donnelly, S Riley, ... Imperial College London 625, 1-6, 2020 | 380 | 2020 |
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis AM Presanis, D De Angelis, ... PLoS medicine 6 (12), e1000207, 2009 | 367 | 2009 |